Loading
Latest filing published 25 Aug 2026 for Theralase Technologies Inc., €2,772. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Arkady Mandel on record concern Theralase Technologies Inc. We count 3 filings; the first trade dates from 7 August 2026 and the latest from 24 August 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 25 August 2026 came the latest disclosure, an option exercise for €2,772 in Theralase Technologies Inc. Filings reach the SEDI feed a median of 1 day after the trade. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations